Quality of life in patients receiving treatment for gynecologic malignancies: Special considerations for patient care

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

1993 • 5,539 citations

Ovarian Cancer

1993 • 3,213 citations

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

1996 • 2,766 citations

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

1999 • 2,474 citations

Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer

1999 • 2,214 citations

Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

1999 • 1,827 citations

Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

2000 • 1,212 citations

Management of cancer pain

1999 • 1,015 citations

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Chemotherapy-Induced Anemia in Adults: Incidence and Treatment

1999 • 918 citations

Chemotherapy-induced peripheral neuropathy

2002 • 914 citations

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

1997 • 775 citations

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1998 • 769 citations

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

1997 • 715 citations

Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

1999 • 678 citations

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.

1997 • 676 citations

Cancer Pain Relief and Palliative Care: Report of a WHO Expert Committee

1991 • 632 citations

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

2001 • 606 citations

The Effect of Debulking Surgery After Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

1995 • 577 citations

Pharmacologic Treatment of Cancer Pain

1996 • 492 citations

Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life

1997 • 478 citations

Changing patient perceptions of the side effects of cancer chemotherapy

2002 • 439 citations

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

2002 • 428 citations

Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology

2002 • 419 citations

Factors influencing quality of life in cancer patients: anemia and fatigue.

1998 • 386 citations

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

1999 • 371 citations

Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes

2002 • 364 citations

NCCN breast cancer clinical practice guidelines in oncology: an update.

2003 • 325 citations

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy

2003 • 320 citations

Cancer-related fatigue: guidelines for evaluation and management.

2001 • 297 citations

Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease

2002 • 295 citations

Female sexual dysfunction: evaluation and treatment.

2000 • 283 citations

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

1993 • 275 citations

Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study

2002 • 273 citations

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

1997 • 267 citations

Measuring the side effects of taxane therapy in oncology

2003 • 264 citations

Reliability and Validity of the Functional Assessment of Cancer Therapy–Ovarian

2001 • 262 citations

Establishing the dose of the oral NK₁ antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting

2003 • 222 citations

Symptomatology of anemia

2001 • 217 citations

Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control

2003 • 212 citations

Epoetin Alfa Treatment Results in Clinically Significant Improvements in Quality of Life in Anemic Cancer Patients When Referenced to the General Population

2003 • 207 citations

Hair and cancer chemotherapy: consequences and nursing care - a literature study

2001 • 202 citations

A nerve-sparing radical hysterectomy: Guidelines and feasibility in Western patients

2001 • 198 citations

Psychological Sequelae and Alopecia Among Women with Cancer

2001 • 190 citations

Recent advances in drug-induced neuropathies

2002 • 167 citations

Clinical Science Review: Comparative Review of 5-HT₃Receptor Antagonists in the Treatment of Acute Chemotherapy-Induced Nausea and Vomiting

2000 • 163 citations

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

1994 • 159 citations

Impact of fatigue on quality of life in oncology patients

2000 • 155 citations

The Impact of Fatigue on Patients with Cancer: Overview of FATIGUE 1 and 2

2000 • 154 citations

Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869

2002 • 145 citations

Randomized Controlled Trial of Single-Agent Paclitaxel Versus Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Recurrent Ovarian Cancer Who Responded to First-Line Platinum-Based Regimens

2002 • 136 citations

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

1994 • 132 citations

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

2002 • 121 citations

Once-weekly dosing of epoetin-? increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy

2003 • 113 citations

Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomes

2003 • 113 citations

A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian Cancer

1989 • 111 citations

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy

2001 • 102 citations

Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine Cervix

1999 • 102 citations

Predictive Factors of Delayed Emesis in Cisplatin-Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or Dexamethasone

1991 • 100 citations

Biological basis of anemia

2001 • 96 citations

Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer.

1998 • 96 citations

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa

2003 • 95 citations

Fatigue: A main component of anemia symptomatology

2001 • 90 citations

Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.

2000 • 87 citations

Chemotherapy-Induced Nausea and Vomiting

2002 • 84 citations

Prevalence of anemia in cancer patients undergoing radiation therapy

2001 • 82 citations

The potential of amifostine: from cytoprotectant to therapeutic agent.

1999 • 81 citations

The problem of pain in outpatients with breast cancer.

1995 • 80 citations

Impact of Ovarian Cancer Perceived by Women

2003 • 79 citations

Neurologic Complications of Cancer Therapy

2011 • 78 citations

Sexual Implications of Gynecologic Cancer Treatments

2000 • 77 citations

Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis

1992 • 76 citations

Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma

2001 • 76 citations

Surviving cancer: The importance of sexual self-concept

1999 • 75 citations

Randomized Controlled Trial of Single-Agent Paclitaxel Versus Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Recurrent Ovarian Cancer Who Responded to First-Line Platinum-Based Regimens

2002 • 74 citations

Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients

2003 • 74 citations

Management of Treatment-Related Toxicity in Advanced Ovarian Cancer

2002 • 74 citations

Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy.

1999 • 68 citations

Neurologic complications of cancer therapy

2003 • 67 citations

Women's experiences following treatment for gynecologic cancer.

1997 • 65 citations

Psychological Sequelae and Alopecia Among Women with Cancer

2001 • 65 citations

Cancer- and Treatment-Related Anemia Clinical Practice Guidelines in Oncology

2005 • 63 citations

Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy

2002 • 55 citations

Quality of Life and Pain in Patients With Recurrent Breast and Gynecologic Cancer

1998 • 53 citations

Fertility preservation in the management of gynecologic cancers

2000 • 51 citations

Pharmacological management of cancer pain.

2000 • 51 citations

Cancer Fatigue: The Way Forward

2003 • 49 citations

Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy

1998 • 47 citations

Quality of life after gestational trophoblastic disease.

2002 • 46 citations

Common symptoms in advanced cancer.

2000 • 46 citations

Symptoms affecting quality of life in women with gynecologic cancer

2002 • 45 citations

Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials.

1997 • 40 citations

Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy

2004 • 39 citations

Quality of life: Gynaecological cancers

2001 • 39 citations

Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine

2002 • 37 citations

Progress in preventing chemotherapy-induced nausea and vomiting.

2002 • 37 citations

Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.

1997 • 36 citations

The pharmacological management of cancer pain

2001 • 35 citations

Pain Management Strategies Used by Patients With Breast and Gynecologic Cancer With Postoperative Pain

2001 • 34 citations

Quality of life issues in the management of ovarian cancer.

1999 • 32 citations

NONOPIOID AND OPIOID ANALGESIC PHARMACOTHERAPY OF CANCER PAIN

1996 • 32 citations

Management of cancer-related anemia: Epoetin alfa and quality of life

2000 • 28 citations

Serotonin Receptor Antagonists in Prophylaxis of Acute and Delayed Emesis Induced by Moderately Emetogenic, Single-Day Chemotherapy

1999 • 28 citations

New agents, new treatment, and antiemetic therapy

2002 • 26 citations

Understanding Peripheral Neuropathy in Patients With Cancer: Background and Patient Assessment

2002 • 26 citations

Ondansetron plus Dexamethasone Compared to the ‘Standard’ Metoclopramide Combination

1993 • 25 citations

Perioperative Epoetin Alfa Increases Red Blood Cell Mass and Reduces Exposure to Transfusions: Results of Randomized Clinical Trials

1998 • 22 citations

Interval debulking surgery in advanced epithelial ovarian cancer

2002 • 22 citations

Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone.

1995 • 19 citations

Patient guide to peripheral neuropathy.

1999 • 18 citations

Ovarian Cancer

2001 • 17 citations

Long time therapy with topotecan in patients with recurrence of ovarian carcinoma.

2002 • 16 citations

Combination Therapy with Granisetron, Methylprednisolone and Droperidol as an Antiemetic Prophylaxis in CDDP-Induced Delayed Emesis for Gynecologic Cancer

2002 • 16 citations

A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin

1999 • 15 citations

Management of stage IA cervical carcinoma.

1996 • 15 citations

Prevalence of anemia in cancer patients undergoing radiation therapy

2001 • 13 citations

Advances in the management of cervical cancer.

2000 • 12 citations

Female sexual dysfunction: definitions, causes, and treatment.

2002 • 12 citations

Acute and chronic pain management in palliative care

2001 • 12 citations

Autologous blood transfusion in radical hysterectomy with and without erythropoietin therapy*1

2002 • 10 citations

The impact of anemia and its treatment on patients with gynecologic malignancies

2002 • 9 citations

The impact of anemia and its treatment on patients with gynecologic malignancies

2002 • 7 citations

Gynecologic malignancy and surgery

1992 • 7 citations

Gynecologic malignancy and surgery: from quantity to quality of life.

1992 • 7 citations

Nonopioid and Opioid Analgesic Pharmacotherapy of Cancer Pain

1997 • 5 citations

The many causes of quality of life deficits in cancer patients

2000 • 4 citations

The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia

2002 • 4 citations

Autologous Blood Transfusion in Radical Hysterectomy With and Without Erythropoietin Therapy

2002 • 3 citations

Clinically meaningful quality-of-life changes in ovarian cancer: Results from gynecologic oncology group clinical trial 152

2003 • 3 citations

RECENT SURGICAL APPROACHES TO GYNECOLOGIC ONCOLOGY

2001 • 2 citations

The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia

2002 • 2 citations

Recent surgical approaches to gynecologic oncology.

2001 • 2 citations

Recent progress in improving quality of life in cancer patients

2000 • 1 citations